Ikarian Capital, LLC
DALLAS TX · SEC CIK 0001778253
$12.32亿2026Q1 申报市值
161持仓数
42.5%前十大占比 · 第一大 8.3%
36 / 53新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q1 买入最多 按季末市值估算
ALMS 新建仓+$2,673.45万
KOD 加仓+$2,081.38万
CLDX 新建仓+$1,463.08万
HROW 加仓+$1,268.30万
ORKA 新建仓+$1,187.11万
2026Q1 卖出最多 按季末市值估算
CIDARA THERAPEUT 清仓-$6,035.66万
JAZZ 减仓-$2,796.18万
RAPT THERAPEUTIC 清仓-$2,253.27万
ABVX 减仓-$1,604.27万
AMGN 清仓-$1,472.90万
2026Q1 持仓明细 点表头排序 · 每页 100 行
导出 CSV 🔒| 代码 | 名称 | 市值 ▼ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| ZBIO | ZENAS BIOPHARMA INC 看涨期权 | $0 | 0.00% | 0 | -46,800 | -100.0% | -$169.93万 | 清仓 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | $0 | 0.00% | 0 | -45,830 | -100.0% | -$160.77万 | 清仓 |
| — | GOSSAMER BIO INC 看跌期权 | $0 | 0.00% | 0 | -500,000 | -100.0% | -$155.00万 | 清仓 |
| — | GOSSAMER BIO INC 看涨期权 | $0 | 0.00% | 0 | -500,000 | -100.0% | -$155.00万 | 清仓 |
| NKTR | NEKTAR THERAPEUTICS 看跌期权 | $0 | 0.00% | 0 | -36,300 | -100.0% | -$153.48万 | 清仓 |
| NKTR | NEKTAR THERAPEUTICS 看涨期权 | $0 | 0.00% | 0 | -36,300 | -100.0% | -$153.48万 | 清仓 |
| INSM | INSMED INC 看涨期权 | $0 | 0.00% | 0 | -8,600 | -100.0% | -$149.67万 | 清仓 |
| TVTX | TRAVERE THERAPEUTICS INC 看涨期权 | $0 | 0.00% | 0 | -36,600 | -100.0% | -$139.85万 | 清仓 |
| — | CATALYST PHARMACEUTICALS INC | $0 | 0.00% | 0 | -57,388 | -100.0% | -$133.94万 | 清仓 |
| — | MIND MEDICINE MINDMED INC | $0 | 0.00% | 0 | -58,803 | -100.0% | -$78.74万 | 清仓 |
| AVTX | AVALO THERAPEUTICS INC | $0 | 0.00% | 0 | — | — | — | 申报中断 |
| GPCR | STRUCTURE THERAPEUTICS INC | $0 | 0.00% | 0 | -4,824 | -100.0% | -$33.55万 | 清仓 |
| — | LYRA THERAPEUTICS INC | $0 | 0.00% | 0 | -21,161 | -100.0% | -$6.52万 | 清仓 |
| — | SYNLOGIC INC | $0 | 0.00% | 0 | -19,966 | -100.0% | -$2.24万 | 清仓 |
| — | ANEBULO PHARMACEUTICALS INC | $0 | 0.00% | 0 | -17,736 | -100.0% | -$1.79万 | 清仓 |